Biocryst Pharmaceuticals: Peers

The FY2025 (Dec) proxy of Biocryst Pharmaceuticals names 18 peer companies for pay. Pay versus performance data of Biocryst Pharmaceuticals for that year is not on file, so it has no rank.

Pay peer group, FY2025 (Dec) proxy

PTC Therapeutics
INSMED
Ultragenyx Pharmaceutical
Mirum Pharmaceuticals
Adma Biologics
Travere Therapeutics
Harmony Biosciences Holdings
Acadia PharmaceuticalsNot disclosedNot disclosed
Amicus TherapeuticsNot disclosedNot disclosed
Apellis PharmaceuticalsNot disclosedNot disclosed
ArdelyxNot disclosedNot disclosed
Arrowhead PharmaceuticalsNot disclosedNot disclosed
Catalyst PharmaceuticalsNot disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Dynavax TechnologiesNot disclosedNot disclosed
Pacira BioSciencesNot disclosedNot disclosed
Rhythm PharmaceuticalsNot disclosedNot disclosed
SIGA TechnologiesNot disclosedNot disclosed
18 companies

Changes by year

FY2025 (Dec) proxy

  • AddedArdelyxpay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
  • AddedCatalyst Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
  • AddedMirum Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
  • AddedRhythm Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
  • RemovedAgenuspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
  • RemovedIronwood Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics

FY2024 (Dec) proxy

  • AddedIronwood Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics
  • AddedPacira BioSciencespay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics
  • RemovedMacroGenicspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.